Table 2.
Patients | Age (years) | Sex | Clinical stage | Histology | Survival after leukocytosis and anemia (days) | Treatment |
---|---|---|---|---|---|---|
1 | 67 | Female | T2bN0M0 | Urothelial | 67 | Cystectomy |
2 | 39 | Female | T4aN0M0 | Urothelial | 12 | Chemoradiation |
3 | 59 | Male | T2N0M0 | Urothelial | 138 | TURBT |
4 | 57 | Male | T4N2M1 | Urothelial | 14 | Chemoradiation |
5 | 60 | Male | T4aN0M0 | Urothelial | 57 | TURBT + chemoradiation |
6 | 63 | Male | T4aN3M0 | Urothelial | 17 | TURBT + chemoradiation |
7 | 43 | Male | T4aN1M0 | Urothelial | 278 | TURBT |
8 | 53 | Male | T4aN0M0 | Urothelial | 12 | TURBT |
9 | 61 | Female | T2N0M0 | Urothelial | 214 | TURBT + chemoradiation |
10 | 54 | Female | T4bN1M0 | Urothelial | 20 | Chemoradiation |
11 | 37 | Female | T4bN1M1 | Mixed | 12 | Chemoradiation |
12 | 57 | Male | T4aN0M1 | Urothelial | 14 | Cystectomy |
13 | 64 | Male | T2N1M0 | Mixed | 74 | Cystectomy |
TURBT: Transurethral resection of bladder